48. Ann Oncol. 2018 Jul 19. doi: 10.1093/annonc/mdy192. [Epub ahead of print]4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC4).Cardoso F(1), Senkus E(2), Costa A(3), Papadopoulos E(4), Aapro M(5), André F(6),Harbeck N(7), Aguilar Lopez B(8), Barrios CH(9), Bergh J(10), Biganzoli L(11),Boers-Doets CB(12), Cardoso MJ(13), Carey LA(14), Cortés J(15), Curigliano G(16),Diéras V(17), El Saghir NS(18), Eniu A(19), Fallowfield L(20), Francis PA(21),Gelmon K(22), Johnston SRD(23), Kaufman B(24), Koppikar S(25), Krop IE(26), MayerM(27), Nakigudde G(28), Offersen BV(29), Ohno S(30), Pagani O(31), Paluch-Shimon S(32), Penault-Llorca F(33), Prat A(34), Rugo HS(35), Sledge GW(36), SpenceD(37), Thomssen C(38), Vorobiof DA(39), Xu B(40), Norton L(41), Winer EP(42).Author information: (1)European School of Oncology (ESO), European Society for Medical Oncology(ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation,Lisbon, Portugal.(2)European Society for Medical Oncology (ESMO) and Department of Oncology andRadiotherapy, Medical University of Gdansk, Gdansk, Poland.(3)European School of Oncology, Milan, Italy.(4)Europa Donna Cyprus, Nicosia, Cyprus.(5)Oncology Department, Clinique de Genolier, Genolier, Switzerland.(6)Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.(7)Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany.(8)Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de laMujer), Mexico DF, Mexico.(9)Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil.(10)Department of Oncology-Pathology, Karolinska Institute & University Hospital,Stockholm, Sweden.(11)European Society of Breast Cancer Specialists (EUSOMA) and Department ofMedical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato,Italy.(12)CB Boers Organization, Wormer, The Netherlands.(13)Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and NovaMedical School, Lisbon, Portugal.(14)Department of Hematology and Oncology, UNC Lineberger Comprehensive CancerCenter, Chapel Hill, USA.(15)Department of Oncology, Vall d' Hebron University, Barcelona, Spain.(16)Division of Early Drug Development, Department of Oncology andHemato-Oncology, European Institute of Oncology, University of Milano, Milano,Italy.(17)Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France.(18)Breast Center of Excellence, American University of Beirut Medical Center,Beirut, Lebanon.(19)Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca,Romania.(20)SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton,UK.(21)Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne,Australia.(22)Medical Oncology Department, BC Cancer Agency, Vancouver, Canada.(23)Department of Medicine, The Royal Marsden, Sutton, UK.(24)Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.(25)Department of Medical Oncology, Bombay Hospital Institute of MedicalSciences, Mumbai, India.(26)Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA.(27)Advanced BC.org, New York, USA.(28)Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization),Kampala, Uganda.(29)European Society of Radiation Oncology (ESTRO) and Department of ExperimentalClinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus,Denmark.(30)Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan.(31)Institute of Oncology of Southern Switzerland, Geneva University Hospitals,Swiss Group for Clinical Cancer Research (SAKK), International Breast CancerStudy Group (IBCSG), Bellinzona, Switzerland.(32)Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel.(33)Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France.(34)IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), HospitalClínic of Barcelona, Translational Genomics and Targeted Therapeutics in SolidTumor, Barcelona, Spain.(35)Breast Oncology Clinical Trials Education, UCSF Helen Diller FamilyComprehensive Cancer Center, San Francisco.(36)Oncology Division, Stanford University Medical Center, Stanford, USA.(37)Policy Department, Breast Cancer Network Australia, Camberwell, VIC,Australia.(38)Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany.(39)Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa.(40)Department of Medical Oncology, Cancer Hospital Chinese Academy of MedicalSciences, Beijing, China.(41)Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, NewYork.(42)Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA.DOI: 10.1093/annonc/mdy192 PMID: 30032243 